Topics

Karolinska Development AB (publ): Karolinska Development's portfolio company Aprea Therapeutics has filed a registration statement relating to its shares of common stock with the U.S. Securities and Exchange Commission

11:41 EDT 9 Sep 2019 | FinanzNachrichten

STOCKHOLM - September 9, 2019. Karolinska Development (Nasdaq Stockholm: KDEV) announces that its portfolio company Aprea Therapeutics has filed a registration statement on September 6, 2019 with t...

Original Article: Karolinska Development AB (publ): Karolinska Development's portfolio company Aprea Therapeutics has filed a registration statement relating to its shares of common stock with the U.S. Securities and Exchange Commission

NEXT ARTICLE

More From BioPortfolio on "Karolinska Development AB (publ): Karolinska Development's portfolio company Aprea Therapeutics has filed a registration statement relating to its shares of common stock with the U.S. Securities and Exchange Commission"

Quick Search